The Dark Side of Discontinuing Weight Loss Medications A new study published in BMJ Medicine reveals the alarming consequences of stopping semaglutide based weight loss medications like Ozempic and Wegovy.
After just two years off medication, patients experience a 22% higher risk of heart attack, stroke, and death compared to those who continued treatment. The problem goes beyond weight regain.
When GLP 1 medications are discontinued, patients experience a resurgence in inflammation, blood pressure, and cholesterol levels that can have devastating consequences for heart health.